Pembrolizumab, Tumor Response, and Survival in Advanced Melanoma
JAMA Author Interviews · American Medical Association
April 19, 20163m 0s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Interview with Antoni Ribas, MD, PhD, author of Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma